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Case Presentation
The patient is a 20-year-old female with a history of asthma 
and anxiety with panic attacks who presented with palpitations 
and lightheadedness/pre-syncope. The morning of admission, 
she was attending a seminar and experienced an acute onset 
of palpitations. The palpitations started while she was seated 
and worsened upon standing. They were associated with 
lightheadedness, shortness of breath, and chest tightness. A 
nurse attending the seminar recommended that she go to the 
emergency room. 
On presentation to the emergency department (ED) her vital signs 
were: Temperature: 99.2°F, Blood pressure (BP): 140/98; Heart 
rate (HR): 140; Respiratory rate (RR): 16; Oxygen saturation: 
100% on room air. She reported that she had experienced 
prior panic attacks but that this episode was persistent and 
significantly more intense in comparison. She also reported that 
a few days prior to presentation she had completed a prolonged 
course of antibiotics for tonsillitis. Her only medications were 
oral contraceptive pills (OCPs) and dextroamphetamine/
amphetamine (Adderall®). She reported taking her Adderall® as 
prescribed, most recently on the day prior to presentation. She 
denied other stimulant or illicit drug abuse. Her family history 
was significant for anti-phospholipid antibody syndrome (APS) 
in her mother. 
Investigations
On physical exam, she was in no acute distress. She had moist 
mucous membranes and no conjunctival pallor. Her cardiac 
exam was remarkable only for tachycardia. The rest of her exam 
was unremarkable. Orthostatic vitals were checked revealing a 
BP of 130/75 and HR of 90-110 beats per minute (bpm) while 
sitting and a BP of 145/97 and HR of 130-150 bpm while standing, 
with associated lightheadedness and shortness of breath. 
Differential Diagnosis
The differential diagnosis included cardiac tachyarrhythmia 
(e.g. supraventricular tachycardia, atrial flutter/fibrillation), 
dehydration, anemia, hyperthyroidism, hypoglycemia, 
pharmacologic stimulant abuse, infection, and pulmonary 
embolism. An electrocardiogram (ECG) revealed sinus 
tachycardia (Figure 1) with no significant ST-T wave changes. 
Labs drawn on admission revealed normal blood counts and 
chemistries, and her thyroid panel revealed an elevated thyroid 
stimulating hormone but normal free T3 and free T4 levels. A 
urine drug screen was positive for amphetamines, consistent 
with her reported use of Adderall® the day prior to presentation. 
Given the acuity of onset of her symptoms, her family history of 
APS, and her OCP use there was a high suspicion for pulmonary 
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Figure 1. Patient’s admission ECG 
1
Valentino, MD, PhD: A Young Female Who Develops Tachycardia and Orthostatic Intolerance Following a Recent Infection
Published by Jefferson Digital Commons, 2013
44
embolism, which was subsequently ruled out with a ventilation/
perfusion scan. She received two 1-liter saline boluses in the ED 
for suspected dehydration, and she was admitted to the general 
medicine service.
The next morning the patient continued to exhibit orthostatic 
intolerance with significant tachycardia upon standing and 
ambulating, associated with shortness of breath and lighthead-
edness/dizziness. Since the initial workup was negative and 
her orthostatic tachycardia continued, the Electrophysiology 
service was consulted. Their differential diagnosis included: 
amphetamine-induced tachycardia, other exogenous 
stimulants, and inappropriate sinus tachycardia. However, 
given the patient’s orthostatic tachycardia with normal BP, her 
age, gender, and recent infection, the most likely diagnosis was 
postural orthostatic tachycardia syndrome (POTS).
Outcome and Follow-up 
On the second day of the patient’s admission, her tachycardia 
improved. Her HR while ambulating peaked in the 110s 
associated with only mild shortness of breath. The decision 
was made not to treat with beta-blockers or calcium channel 
blockers since she remained hemodynamically stable and only 
minimally symptomatic. She was instructed to discontinue the 
Adderall® and avoid any other stimulants, including caffeine. She 
was to follow-up with Electrophysiology at Thomas Jefferson 
University Hospital and to schedule an outpatient tilt table test. 
Discussion
Orthostatic intolerance is defined as cerebral hypoperfusion or 
sympathetic activation while standing, relieved by recumbency. 
POTS is a clinical syndrome characterized by orthostatic 
intolerance without orthostatic hypotension.1 The accepted 
definition of POTS is orthostatic intolerance with a rise in HR of 
>30 bpm within 10 minutes of head-up tilt or standing, or a HR 
of >120 bpm while upright, without orthostatic hypotension.2 
The majority of patients with POTS are young females, with an 
average age of 30 years.3 The most common symptoms are those 
related to cerebral hypoperfusion and sympathetic activation.1 
Fatigue is also a common symptom, and many patients have 
poor exercise tolerance.1 While most patients cannot identify 
an inciting event, some patients recall an antecedent viral 
illness, while others associate the onset of symptoms with recent 
surgery or trauma.1,4
Several pathophysiologic mechanisms have been proposed to 
underlie POTS. About 50% of patients with POTS have regional 
autonomic denervation, typically in the lower limbs. Sympathetic 
denervation of the lower extremities, as demonstrated by a 
quantitative sudomotor axon reflex test (QSART), thermoregu-
latory sweat test, and impaired norepinephrine spillover in the 
lower extremities in response to various stimuli, can cause loss of 
vasomotor tone and pooling of blood in the legs.3,5 This can cause 
a decrease in preload upon standing and a reflexive increase in 
sympathetic stimulation of the heart in order to maintain cardiac 
output. The cause of this peripheral sympathetic denervation is 
still unclear, but ganglionic (α3) acetylcholine receptor (AChR) 
antibodies have been demonstrated in ~15% of patients with 
POTS indicating a possible autoimmune mechanism.3
Another subset of POTS is characterized by a hyperadrenergic 
state with elevated plasma norepinephrine levels (>600 pg/mL) 
and a rise in BP on standing.4 In a recent study, 29% of patients 
with POTS had elevated plasma levels of norepinephrine upon 
standing, and these patients benefited the most from β-blockade.3 
In some patients, hypovolemia may also contribute to the 
manifestation of POTS. Dysfunction of the renin-angiotensin-
aldosterone system has been implicated as a cause of the 
hypovolemia observed in some patients with POTS, as these 
patients lack a compensatory increase in circulating renin and 
aldosterone despite low plasma volume.6,7
Several investigations should be made to establish the diagnosis 
of POTS including: orthostatic vitals (head-up tilt or standing), 
QSART response, thermoregulatory sweat test, supine and 
standing norepinephrine measurements, and 24-hour urine 
sodium excretion (surrogate marker for plasma volume).3 
Pharmacologic treatments for POTS are aimed at increasing 
plasma volume (fludrocortisone, erythropoietin), enhancing 
venous return to the heart (midodrine, octreotide), or 
counteracting a hyperadrenergic state (β-blockers, clonidine, 
pyridostigmine, disopyramide).3,4 Nonpharmacologic treatments 
for POTS include high salt intake, water repletion, small 
frequent meals, regular exercise, and compression stockings. 
Typically, treatment is tailored toward the suspected underlying 
mechanism determined from autonomic testing. 
Key Points
POTS is a disorder that is most common in young females 
and characterized by orthostatic intolerance without a decline 
in blood pressure. The syndrome may have several etiologies, 
which include peripheral denervation with lower extremity 
pooling of blood, a hyperadrenergic state, and low plasma 
volume. In a significant number of patients, the symptoms of 
POTS are manifested shortly after an infection, as occurred in 
our patient’s case, or following other stressful events such as 
surgery or trauma. Initial work-up includes ruling out common 
etiologies for tachycardia, including: cardiac tachyarrhythmia, 
anemia, stimulant abuse, dehydration, pulmonary embolism, 
and hyperthyroidism. The patient should have orthostatic vitals 
measured or undergo a formal tilt table test. An increase in 
HR of >30 bpm or a HR of >120 bpm upon standing, without 
orthostatic hypotension, correlates with a diagnosis of POTS. 
The patient should then undergo autonomic testing as outlined 
above to determine the etiology of the patient’s orthostatic 
intolerance and determine the most appropriate therapy. 
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